Your browser doesn't support javascript.
loading
A C-Met chemical inhibitor promotes fracture healing through interacting with osteogenic differentiation via the mTORC1 pathway.
Wang, Rongliang; Xu, Xingquan; Li, Yixuan; Li, Jiawei; Yao, Chen; Wu, Rui; Jiang, Qing; Shi, Dongquan.
Afiliação
  • Wang R; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Xu X; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Li Y; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Li J; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Yao C; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Wu R; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Jiang Q; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
  • Shi D; State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China; Joint Research Center for Bone and
Exp Cell Res ; 381(1): 50-56, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31034806

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteogênese / Piridonas / Transdução de Sinais / Consolidação da Fratura / Proteínas Proto-Oncogênicas c-met / Alvo Mecanístico do Complexo 1 de Rapamicina / Aminopiridinas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteogênese / Piridonas / Transdução de Sinais / Consolidação da Fratura / Proteínas Proto-Oncogênicas c-met / Alvo Mecanístico do Complexo 1 de Rapamicina / Aminopiridinas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article